Mealey's (November 11, 2020, 9:36 AM EST) -- MINNEAPOLIS — A federal judge in Minnesota in a Nov. 9 order dismissed with prejudice all claims in a lawsuit accusing the nation’s four largest pharmacy benefit managers (PBMs) of breaching their fiduciary duties by allegedly negotiating rebates and other savings from Mylan Pharmaceuticals and other entities for the sale of EpiPens and failing to pass those savings along to the purchasers (In re: EpiPen ERISA Litigation, No. 17-1884, D. Minn.)....